The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: PCRC-Supported Legacy Intervention in Pediatric Palliative Care
Official Title: Impact of a PCRC-Supported Legacy Intervention in Pediatric Palliative Care
Study ID: NCT04059393
Brief Summary: This trial studies how well a web-based legacy intervention works in improving the quality of life in caregivers and younger patients with cancer that has come back (recurrent) or does not respond to treatment (refractory). Legacy-making, defined as doing or saying something to be remembered, may reduce the suffering of children with cancer and their caregivers. Currently, there is little information about what kinds of legacy-making activities are helpful from the perspective of children. Using a web-based digital storytelling intervention, this study may help researchers examine what children think about these legacy-making activities and what kinds of activities might be helpful to them.
Detailed Description: PRIMARY OBJECTIVES: I. To examine the impact of legacy-making on coping strategies and adjustment outcomes among children with refractory or relapsed cancer. II. To examine the impact of legacy-making on coping strategies and adjustment outcomes among parent caregivers. III. To examine the process of implementing a web-based legacy-making intervention for children with refractory or relapsed cancer and their parent caregivers by obtaining parent self-reports (e.g., What did you and your child-like/not like about the intervention? How difficult was it to complete the intervention? What made it difficult? What else you would like to teach us?). OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I: Patients participate in a web-based legacy intervention by answering questions about themselves and uploading videos, photographs, and music to create a digital story within 2 weeks. GROUP II: Patients receive standard of care. Patients have the option to participate in the web-based legacy intervention after 2 months.
Minimum Age: 7 Years
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: Yes
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Name: Terrah Akard, PhD
Affiliation: Vanderbilt-Ingram Cancer Center
Role: PRINCIPAL_INVESTIGATOR